Next Post

Seattle's AVM Biotechnology Expands Executive Team in Preparation for Oncology and COVID-19 Clinical Trials

SEATTLE, WA, USA, July 8, 2020 /⁨EINPresswire.com⁩/ — Seattle’s AVM Biotechnology, an up-and-coming biotech firm whose lead molecule, AVM0703, has received FDA permission to begin clinical trials treating no-option Non-Hodgkin’s Lymphoma and is …
Next Post

Seattle's AVM Biotechnology Expands Executive Team in Preparation for Oncology and COVID-19 Clinical Trials

SEATTLE, WA, USA, July 8, 2020 /⁨EINPresswire.com⁩/ — Seattle’s AVM Biotechnology, an up-and-coming biotech firm whose lead molecule, AVM0703, has received FDA permission to begin clinical trials treating no-option Non-Hodgkin’s Lymphoma and is …
Next Post

Seattle's AVM Biotechnology Expands Executive Team in Preparation for Oncology and COVID-19 Clinical Trials

SEATTLE, WA, USA, July 8, 2020 /⁨EINPresswire.com⁩/ — Seattle’s AVM Biotechnology, an up-and-coming biotech firm whose lead molecule, AVM0703, has received FDA permission to begin clinical trials treating no-option Non-Hodgkin’s Lymphoma and is …